Compounds > blp 1654
Page last updated: 2024-09-05

blp 1654 and Gram-Negative Bacterial Infections

blp 1654 has been researched along with Gram-Negative Bacterial Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bodey, GP; Horikoshi, N; Rodriguez, V1

Trials

1 trial(s) available for blp 1654 and Gram-Negative Bacterial Infections

ArticleYear
Human pharmacology of 6-[D-alpha-(3-guanylureido)-phenylacetamido]-penicillanic acid (BL-P1654).
    Antimicrobial agents and chemotherapy, 1974, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; Middle Aged; Neoplasms; Penicillanic Acid

1974